• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物衍生的氧化三甲胺及其与更严重房颤形式的关联:房颤风险研究结果

Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study.

作者信息

Nguyen B O, Meems L M G, van Faassen M, Crijns H J G M, van Gelder I C, Kuipers F, Rienstra M

机构信息

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

出版信息

Int J Cardiol Heart Vasc. 2021 May 24;34:100798. doi: 10.1016/j.ijcha.2021.100798. eCollection 2021 Jun.

DOI:10.1016/j.ijcha.2021.100798
PMID:34095450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8167185/
Abstract

INTRODUCTION

The importance of gut microbiome in cardiovascular disease has been increasingly recognized. Trimethylamine N-oxide (TMAO) is a gut microbe-derived metabolite that is associated with cardiovascular disease, including atrial fibrillation (AF). The role of TMAO in clinical AF progression however remains unknown.

METHODS AND RESULTS

In this study we measured TMAO and its precursor (betaine, choline, and L- carnitine) levels in 78 patients using plasma samples from patients that participated in the AF-RISK study. 56 patients suffered from paroxysmal AF and 22 had a short history of persistent AF. TMAO levels were significantly higher in patients with persistent AF, as compared to those with paroxysmal AF (median [IQR] 5.65 [4.7-9.6] / versus 4.31 [3.2-6.2] /, p < 0.05), while precursor levels did not differ. In univariate analysis, we observed that for every unit increase in TMAO, the odds for having persistent AF increased with 0.44 [0.14-0.73], p < 0.01. Conclusion: These results suggest that higher levels of TMAO are associated with more progressed forms of AF. We therefore hypothesize that increased TMAO levels may reflect disease progression in humans. Larger studies are required to validate these preliminary findings. Clinicaltrials.gov NCT01510210.

摘要

引言

肠道微生物群在心血管疾病中的重要性已得到越来越多的认可。氧化三甲胺(TMAO)是一种源自肠道微生物的代谢产物,与心血管疾病相关,包括心房颤动(AF)。然而,TMAO在临床房颤进展中的作用仍不清楚。

方法与结果

在本研究中,我们使用参与AF-RISK研究患者的血浆样本,测量了78例患者的TMAO及其前体(甜菜碱、胆碱和左旋肉碱)水平。56例患者患有阵发性房颤,22例有短暂的持续性房颤病史。与阵发性房颤患者相比,持续性房颤患者的TMAO水平显著更高(中位数[四分位间距]5.65[4.7 - 9.6]/对4.31[3.2 - 6.2]/,p < 0.05),而前体水平无差异。在单变量分析中,我们观察到TMAO每增加一个单位,发生持续性房颤的几率增加0.44[0.14 - 0.73],p < 0.01。结论:这些结果表明,较高水平的TMAO与更严重形式的房颤相关。因此,我们假设TMAO水平升高可能反映人类疾病进展。需要更大规模的研究来验证这些初步发现。Clinicaltrials.gov NCT01510210。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/8167185/1bda85711a2c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/8167185/c35e81e89eb7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/8167185/1bda85711a2c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/8167185/c35e81e89eb7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/8167185/1bda85711a2c/gr2.jpg

相似文献

1
Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study.肠道微生物衍生的氧化三甲胺及其与更严重房颤形式的关联:房颤风险研究结果
Int J Cardiol Heart Vasc. 2021 May 24;34:100798. doi: 10.1016/j.ijcha.2021.100798. eCollection 2021 Jun.
2
Trimethylamine N-oxide in atrial fibrillation progression.房颤进展中的氧化三甲胺
Int J Cardiol Heart Vasc. 2020 Jun 11;29:100554. doi: 10.1016/j.ijcha.2020.100554. eCollection 2020 Aug.
3
A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.肠道微生物与心房颤动的潜在关系:三甲基胺 N-氧化物,一种源自肠道微生物的代谢物,促进了心房颤动的发展。
Int J Cardiol. 2018 Mar 15;255:92-98. doi: 10.1016/j.ijcard.2017.11.071.
4
Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.宏基因组数据挖掘揭示了心房颤动患者肠道微生物群中三甲胺-N-氧化物合成的富集。
BMC Genomics. 2020 Jul 30;21(1):526. doi: 10.1186/s12864-020-06944-w.
5
A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.一项关于肠道微生物群依赖的代谢产物三甲胺 N-氧化物与心房颤动发生率的系统评价和荟萃分析。
Ann Palliat Med. 2021 Nov;10(11):11512-11523. doi: 10.21037/apm-21-2763.
6
The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies.肠道微生物衍生代谢物三甲胺 N-氧化物与心房颤动:关系、机制与治疗策略。
Clin Interv Aging. 2021 Nov 30;16:1975-1986. doi: 10.2147/CIA.S339590. eCollection 2021.
7
Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.肠道微生物代谢产物三甲胺 N-氧化物与房颤患者血栓形成有关。
Am J Med Sci. 2019 Dec;358(6):422-428. doi: 10.1016/j.amjms.2019.09.002. Epub 2019 Sep 19.
8
Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women.食用全蛋可增加超重绝经后女性的血浆胆碱和甜菜碱水平,而不影响氧化三甲胺水平或肠道微生物群。
Nutr Res. 2020 Jun;78:36-41. doi: 10.1016/j.nutres.2020.04.002. Epub 2020 Apr 22.
9
Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.血清三甲胺 N-氧化物浓度与高血压患者首次中风呈正相关。
Stroke. 2018 Sep;49(9):2021-2028. doi: 10.1161/STROKEAHA.118.021997.
10
Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.血浆中三甲胺 N-氧化物水平升高与房颤事件相关。
Int J Cardiol. 2018 Sep 15;267:100-106. doi: 10.1016/j.ijcard.2018.04.128.

引用本文的文献

1
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons.解读肠道-器官轴中的氧化三甲胺:从生物标志物、细胞死亡机制到治疗前景
Drug Des Devel Ther. 2025 Apr 29;19:3363-3393. doi: 10.2147/DDDT.S512207. eCollection 2025.
2
The Impact of Trimethylamine N-Oxide on Atrial Fibrillation Presence in Patients with Cardiovascular Disease.氧化三甲胺对心血管疾病患者心房颤动发生的影响
J Xenobiot. 2025 Feb 7;15(1):28. doi: 10.3390/jox15010028.
3
Inflammatory gut-heart interactions: Is there a link between inflammatory bowel disease and atrial fibrillation?

本文引用的文献

1
Gut Microbiota and Cardiovascular Disease.肠道微生物群与心血管疾病。
Circ Res. 2020 Jul 31;127(4):553-570. doi: 10.1161/CIRCRESAHA.120.316242. Epub 2020 Jul 30.
2
Rosuvastatin alters the genetic composition of the human gut microbiome.瑞舒伐他汀改变了人类肠道微生物组的基因组成。
Sci Rep. 2020 Mar 25;10(1):5397. doi: 10.1038/s41598-020-62261-y.
3
Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study.在表型良好的患者中,心房颤动进展的危险因素及相关心血管结局:来自 AF-RISK 研究的数据。
炎症性肠-心相互作用:炎症性肠病与心房颤动之间存在关联吗?
Int J Cardiol Heart Vasc. 2024 Oct 16;55:101537. doi: 10.1016/j.ijcha.2024.101537. eCollection 2024 Dec.
4
Pre-procedural TMAO as a predictor for recurrence of atrial fibrillation after catheter ablation.术前三甲胺氧化物作为导管消融术后房颤复发的预测指标。
BMC Cardiovasc Disord. 2024 Dec 28;24(1):750. doi: 10.1186/s12872-024-04170-w.
5
Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation.遗传学、转录组学、宏基因组学和代谢组学在心房颤动的发病机制及预测中的作用
Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv33-iv40. doi: 10.1093/eurheartjsupp/suae072. eCollection 2024 Jul.
6
Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.肠道微生物群在心血管疾病发病机制中的作用的机制综述。
Cardiovasc Hematol Disord Drug Targets. 2024;24(1):13-39. doi: 10.2174/011871529X310857240607103028.
7
Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of resveratrol and its derivatives.膳食氧化三甲胺前体的心血管风险以及白藜芦醇及其衍生物的治疗潜力。
FEBS Open Bio. 2024 Mar;14(3):358-379. doi: 10.1002/2211-5463.13762. Epub 2024 Jan 21.
8
Recent highlights on the mechanistic basis of cardiovascular remodeling from the .来自……的关于心血管重塑机制基础的近期亮点
Int J Cardiol Heart Vasc. 2023 Jul 21;47:101248. doi: 10.1016/j.ijcha.2023.101248. eCollection 2023 Aug.
9
Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies.肠道微生物群与心房颤动:发病机制、作用机制及治疗方法
Arrhythm Electrophysiol Rev. 2023 Apr 19;12:e14. doi: 10.15420/aer.2022.33. eCollection 2023.
10
Association of gut microbiome dysbiosis with the progression of atrial fibrillation: A systematic review.肠道微生物群落失调与心房颤动进展的关联:系统评价。
Ann Noninvasive Electrocardiol. 2023 Jul;28(4):e13059. doi: 10.1111/anec.13059. Epub 2023 Mar 20.
Europace. 2020 Mar 1;22(3):352-360. doi: 10.1093/europace/euz339.
4
Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.肠道微生物群在心血管健康和疾病中的作用:美国心脏病学会最新综述。
J Am Coll Cardiol. 2019 Apr 30;73(16):2089-2105. doi: 10.1016/j.jacc.2019.03.024.
5
A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.促炎肠道微生物群增加全身炎症并加速动脉粥样硬化。
Circ Res. 2019 Jan 4;124(1):94-100. doi: 10.1161/CIRCRESAHA.118.313234.
6
Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.血浆中三甲胺 N-氧化物水平升高与房颤事件相关。
Int J Cardiol. 2018 Sep 15;267:100-106. doi: 10.1016/j.ijcard.2018.04.128.
7
Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography.经光学相干断层扫描评估,冠心病患者的血浆三甲胺 N-氧化物与易损斑块特征相关。
Int J Cardiol. 2018 Aug 15;265:18-23. doi: 10.1016/j.ijcard.2018.04.126. Epub 2018 Apr 28.
8
A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.肠道微生物与心房颤动的潜在关系:三甲基胺 N-氧化物,一种源自肠道微生物的代谢物,促进了心房颤动的发展。
Int J Cardiol. 2018 Mar 15;255:92-98. doi: 10.1016/j.ijcard.2017.11.071.
9
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.肠道微生物生成的代谢产物三甲胺 N-氧化物作为心血管风险生物标志物:系统评价和剂量反应荟萃分析。
Eur Heart J. 2017 Oct 14;38(39):2948-2956. doi: 10.1093/eurheartj/ehx342.